Harrison's Hour - Heart Failure

20 Questions | By JDomingo | Last updated: Mar 20, 2022 | Total Attempts: 97

Questions

Settings

Create your own Quiz

Questions and Answers

1.

1. The measurement of this biomarker is useful for establishing prognosis or disease severity in chronic HF and can be useful to achieve optimal dosing of medical therapy in select clinically euvolemic patients. PAGE 1505
- A.
  
  A. Soluble ST-2
- B.
  
  B. Galectin-3
- C.
  
  C. Troponin I
- D.
  
  D. B-type natriuretic peptide
2.

2. A heterogenous clinical syndrome most often resulting in need for hospitalization due to confluence of interrelated abnormalities of decreased cardiac performance, renal dysfunction, and alteration in vascular compliance? PAGE 1507
- A.
  
  A. Acute decompensated heart failure
- B.
  
  B. Heart failure with reduce ejection fraction
- C.
  
  C. Heart failure with preserve ejection fraction
- D.
  
  D. Advanced heart failure
3.

3. What are the cardinal symptoms of HF? PAGE 1503
- A.
  
  A. Fatigue and Orthopnea
- B.
  
  B. SOB and Tachycardia
- C.
  
  C. Fatigue and SOB
- D.
  
  D. PND and Orthopnea
4.

4. How will you classify patient with HF describe as mild limitation of physical activity with symptoms occurring during ordinary activity? PAGE 1501
- A.
  
  A. NYHA I
- B.
  
  B. NYHA II
- C.
  
  C. NYHA III
- D.
  
  D. NYHA IV
5.

5. What is the drug that exerts a mild inotropic effect, attenuate carotid sinus baroreceptor activity, and are sympathoinhibitory? PAGE 1512
- A.
  
  A. Furosemide
- B.
  
  B. Enalapril
- C.
  
  C. Digoxin
- D.
  
  D. Carvedilol
6.

6. Which of the following causes depressed EF in HF? PAGE 1501
- A.
  
  A. Hypertrophic Cardiomyopathy
- B.
  
  B. Restrictive Cardiomyopathy
- C.
  
  C. Dilated Cardiomyopathy
- D.
  
  D. Thyrotoxicosis
7.

7. What are the cornerstones of therapy of CHF? PAGE 1511
- A.
  
  A. ACE-I and CCB
- B.
  
  B. ACE-I and BB
- C.
  
  C. ACE-I and Diuretics
- D.
  
  D. ACE-I and ARBS
8.

8. First line of therapy in volume overload with congestion? Page 1510
- A.
  
  A. Spironolactone
- B.
  
  B. Eplerenone
- C.
  
  C. Furosemide
- D.
  
  D.Hydrochlorothiazide
9.

9. The following statement are TRUE regarding Cor Pulmonale, EXCEPT? PAGE 1505-1506
- A.
  
  A. often referred as pulmonary heart disease
- B.
  
  B. defined as altered RV structure and/or function in the context of chronic lung disease
- C.
  
  C. develops only in chronic changes in the pulmonary vasculature
- D.
  
  D. the most common cause of right HF is Left HF
10.

10. It augurs a poor overall prognosis when present in patient with HF? Page 1504
- A.
  
  A. peripheral edema
- B.
  
  B. cardiac cachexia
- C.
  
  C. ascites
- D.
  
  D. jaundice
11.

11. Gold standard for assessing LV mass and volume? Page 1505
- A.
  
  A. 12-L ECG
- B.
  
  B. 2-D echo
- C.
  
  C. Holter monitoring
- D.
  
  D. MRI
12.

12. The following conditions can also lead to HF with a preserved EF? Page 1501
- A.
  
  A. Cor pulmonale
- B.
  
  B. Myocardial infarction
- C.
  
  C. Hypertension
- D.
  
  D. Metabolic disorder
13.

13. A condition wherein it refers to the changes in LV mass, volume, and shape and the composition of the heart that occur after cardiac injury and/or abnormal hemodynamic loading conditions. PAGE 1503
- A.
  
  A. Ventricular remodeling
- B.
  
  B. Elevated LV end-diastolic filling
- C.
  
  C. LV hypertrophy
- D.
  
  D. Myocardial ischemia
14.

14. A clinical manifestation of HF which results from redistribution of fluid from splanchnic circulation and lower extremities into central circulation during recumbency? Page 1503
- A.
  
  A. Orthopnea
- B.
  
  B. PND
- C.
  
  C. Dyspnea
- D.
  
  D. Platypnea
15.

15. What is the cause of sudden cardiac death(SCD) in approximately half of patients with HF and is particularly prevalent in HFrEF patients with early stage of disease? PAGE 1514
- A.
  
  A. ventricular arryhthmia
- B.
  
  B. atrial fibrillation
- C.
  
  C. LBBB
- D.
  
  D. RBBB
16.

16. It provides estimation of Right atrial pressure? PAGE 1504
- A.
  
  A. JVP
- B.
  
  B. PP
- C.
  
  C. MAP
- D.
  
  D. SV
17.

17. All are true about Cheyne-Stokes respiration EXCEPT? PAGE 1504
- A.
  
  A. Referred as periodic respiration
- B.
  
  B. Usually assoc. with low cardiac output
- C.
  
  C. Increased sensitivity of the respiratory center to arterial O2
- D.
  
  D. Stimulate the respiratory center resulting in hyperventilation, hypocapnia, followed by recurrence of apnea
18.

18. What is the treatment that has been shown to be associated with modestly improved clinical outcomes in patients with HFrEF? PAGE 1513
- A.
  
  A. Omega-3 polyunsatureted fatty acids
- B.
  
  B. Rosuvastatin
- C.
  
  C. Aspirin
- D.
  
  D. Amlodipine
19.

19. The following Beta-blockers should restrictedly use in HFrEF, EXCEPT? PAGE 1511
- A.
  
  A. carvedilol
- B.
  
  B. propranolol
- C.
  
  C. metoprolol succinate
- D.
  
  D. bisoprolol
20.

20. What is the procedure considered in patients with ischemic cardiomyopathy with multivessel coronary artery disease? PAGE 1514
- A.
  
  A. Coronary angioplasty
- B.
  
  B. Coronary angiography
- C.
  
  C. Coronary artery bypass grafting
- D.
  
  D. Optimal medical therapy